Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Syk Kinase Inhibitor Rapidly Reduces Disease Activity in RA
Link ID 10133
Title Syk Kinase Inhibitor Rapidly Reduces Disease Activity in RA
Url http://www.medscape.com/viewarticle/582711?src=rss
Description A new class of oral drugs for treatment of rheumatoid arthritis -- Syk kinase inhibitors -- produces a rapid reduction in disease activity, according to results of a phase II trial presented Monday at the American College of Rheumatology Annual Scientific Meeting in San Francisco. Reuters Health Information
Category Articles > Rheumatology
Keywords
Date Oct 30, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Rheumatology
1. Lymphocyte Aggregates Predict Better Infliximab Response in Rheumatoid Arthritis
  Patients with rheumatoid arthritis (RA) with synovial lymphocyte aggregates respond better to the anti-tumor necrosis factor (anti-TNF) agent infliximab than those with only diffuse leukocyte infiltration, researchers from the Netherlands report. Reuters Health Information
Category:   Articles > Rheumatology


2. Therapy Insight: The Changing Spectrum of Rheumatic Disease in HIV Infection
  The impact of the global HIV pandemic continues to grow and rheumatologists need to be aware of the spectrum of rheumatic diseases that occur in HIV-positive individuals, as outlined in this review.
Nature Clinical Practice Rheumatology
Category:   Articles > Rheumatology


3. Long-Term Abatacept Safe, Usually Effective for Juvenile Idiopathic Arthritis
  Four out of five children with juvenile idiopathic arthritis had a good clinical response to abatacept during a long-term open-label extension trial. The safety profile was good, and the level of response often increased as treatment went on, the researchers report. Reuters Health Information
Category:   Articles > Rheumatology


4. Cytokine Disturbances in Systemic Lupus ErythematosusCytokine Disturbances in Systemic Lupus Erythem
  Cytokines are receiving great attention as candidate biomarkers for disease activity and targets of novel biologic agents for SLE. Arthritis Research & Therapy
Category:   Articles > Rheumatology


5. Golimumab Effective for Psoriatic Arthritis
  Golimumab, a human monoclonal antibody against tumor necrosis factor (TNF)-alpha administered subcutaneously, is effective in treating psoriatic arthritis and its associated skin and nail lesions, according to a report in the April issue of Arthritis & Rheumatism. Reuters Health Information
Category:   Articles > Rheumatology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS